Exeltis' global infrastructure and deep market knowledge make them an ideal partner to maximize the impact of our innovative formulation." Salustiano Perez, CEO of Exeltis, adds: " We are thrilled to ...
Exeltis USA, Inc. (Exeltis), a global pharmaceutical company specializing in women’s health, announced that the U.S. Food and Drug Administration (FDA) has approved an update to the labeled strength ...
Drospirenone Only Pill (DOP) is the first research novel product approved by the European Health Authorities for Exeltis and the entire Insud Pharma group DOP is safer than combined contraceptives ...
The FDA has torn into Exeltis over a social media sponsored post for birth control pill Slynd, lambasting the drugmaker for leaving out all the risk information, making misleading efficacy claims and ...
New Delhi: Lupin and Exeltis Healthcare announced that the Spanish Ministry of Health (MSCBC) has approved the reimbursement of Lupin’s NaMuscla (mexiletine) for the symptomatic treatment of myotonia ...
Women's health pharma Exeltis USA has been reprimanded by the FDA for making a Facebook post that promoted its birth control product Slynd, overstating its efficacy and failing to mention potential ...
FLORHAM PARK, N.J.--(BUSINESS WIRE)--Exeltis USA, Inc., a division of the global pharmaceutical group Insud Pharma, today announced “Let’s Love Every Body,” a national campaign designed to empower ...
The biotech arm of Spain's Grupo Chemo earlier this year bought a contract manufacturer in Spain specializing in monoclonal antibodies as part of its ambitions to produce biosimilars. Now its pharma ...
NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, has ...
New Delhi, Drug maker Lupin on Thursday said its US-based unit has inked a pact with Exeltis Inc to promote Solosec, a drug used to treat bacterial vaginosis in women. As part of the tie up, Exeltis ...
The US Food and Drug Administration (FDA) recently sent Exeltis USA an untitled letter citing the company for a Facebook post promoting its birth control pill Slynd (drospirenone) without fully ...
The Food and Drug Administration (FDA) has taken a firm stance against misleading advertising practices by issuing a warning to Exeltis, the manufacturer of the progesterone-only birth control pill, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results